UniProt ID | SETD3_HUMAN | |
---|---|---|
UniProt AC | Q86TU7 | |
Protein Name | Histone-lysine N-methyltransferase setd3 | |
Gene Name | SETD3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 594 | |
Subcellular Localization | Nucleus . | |
Protein Description | Histone methyltransferase that methylates 'Lys-4' and 'Lys-36' of histone H3 (H3K4me and H3K36me). Acts as a transcriptional activator. Plays an important role in the transcriptional regulation of muscle cell differentiation via interaction with MYOD1.. | |
Protein Sequence | MGKKSRVKTQKSGTGATATVSPKEILNLTSELLQKCSSPAPGPGKEWEEYVQIRTLVEKIRKKQKGLSVTFDGKREDYFPDLMKWASENGASVEGFEMVNFKEEGFGLRATRDIKAEELFLWVPRKLLMTVESAKNSVLGPLYSQDRILQAMGNIALAFHLLCERASPNSFWQPYIQTLPSEYDTPLYFEEDEVRYLQSTQAIHDVFSQYKNTARQYAYFYKVIQTHPHANKLPLKDSFTYEDYRWAVSSVMTRQNQIPTEDGSRVTLALIPLWDMCNHTNGLITTGYNLEDDRCECVALQDFRAGEQIYIFYGTRSNAEFVIHSGFFFDNNSHDRVKIKLGVSKSDRLYAMKAEVLARAGIPTSSVFALHFTEPPISAQLLAFLRVFCMTEEELKEHLLGDSAIDRIFTLGNSEFPVSWDNEVKLWTFLEDRASLLLKTYKTTIEEDKSVLKNHDLSVRAKMAIKLRLGEKEILEKAVKSAAVNREYYRQQMEEKAPLPKYEESNLGLLESSVGDSRLPLVLRNLEEEAGVQDALNIREAISKAKATENGLVNGENSIPNGTRSENESLNQESKRAVEDAKGSSSDSTAGVKE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Ubiquitination | KSRVKTQKSGTGATA CCCCCCCCCCCCCCC | 56.96 | - | |
12 | Phosphorylation | SRVKTQKSGTGATAT CCCCCCCCCCCCCCC | 31.59 | 22617229 | |
12 (in isoform 2) | Phosphorylation | - | 31.59 | - | |
14 (in isoform 2) | Phosphorylation | - | 30.63 | - | |
14 | Phosphorylation | VKTQKSGTGATATVS CCCCCCCCCCCCCCC | 30.63 | 25159151 | |
17 (in isoform 2) | Phosphorylation | - | 24.98 | - | |
17 | Phosphorylation | QKSGTGATATVSPKE CCCCCCCCCCCCHHH | 24.98 | 16094384 | |
19 | Phosphorylation | SGTGATATVSPKEIL CCCCCCCCCCHHHHH | 19.70 | 28450419 | |
21 | Phosphorylation | TGATATVSPKEILNL CCCCCCCCHHHHHHH | 26.37 | 25849741 | |
23 | Ubiquitination | ATATVSPKEILNLTS CCCCCCHHHHHHHHH | 50.29 | - | |
35 | Ubiquitination | LTSELLQKCSSPAPG HHHHHHHHCCCCCCC | 35.73 | - | |
38 | Phosphorylation | ELLQKCSSPAPGPGK HHHHHCCCCCCCCCC | 34.25 | 23312004 | |
74 | Ubiquitination | LSVTFDGKREDYFPD CEEEECCCCHHHCHH | 55.23 | - | |
74 | 2-Hydroxyisobutyrylation | LSVTFDGKREDYFPD CEEEECCCCHHHCHH | 55.23 | - | |
115 | Ubiquitination | LRATRDIKAEELFLW CEECCCCCHHHHHHE | 54.77 | - | |
133 | Phosphorylation | KLLMTVESAKNSVLG HHHHHHHHHHHCCCC | 39.96 | 30631047 | |
181 | Phosphorylation | PYIQTLPSEYDTPLY HHHHCCCCCCCCCCC | 52.48 | 26074081 | |
183 | Phosphorylation | IQTLPSEYDTPLYFE HHCCCCCCCCCCCCC | 29.47 | 26074081 | |
217 | Phosphorylation | YKNTARQYAYFYKVI HHHHHHHHHHHHHHH | 9.56 | 29083192 | |
219 | Phosphorylation | NTARQYAYFYKVIQT HHHHHHHHHHHHHHH | 11.51 | 28555341 | |
221 | Phosphorylation | ARQYAYFYKVIQTHP HHHHHHHHHHHHHCC | 7.53 | 28555341 | |
232 | Ubiquitination | QTHPHANKLPLKDSF HHCCCCCCCCCCCCC | 52.87 | - | |
244 | Phosphorylation | DSFTYEDYRWAVSSV CCCCHHHHHHHHHHH | 8.98 | - | |
249 | Phosphorylation | EDYRWAVSSVMTRQN HHHHHHHHHHHHHCC | 14.96 | 23403867 | |
250 | Phosphorylation | DYRWAVSSVMTRQNQ HHHHHHHHHHHHCCC | 14.87 | 23403867 | |
253 | Phosphorylation | WAVSSVMTRQNQIPT HHHHHHHHHCCCCCC | 27.26 | 23403867 | |
340 | Acetylation | SHDRVKIKLGVSKSD CCCCEEEEECCCHHH | 33.21 | 25953088 | |
345 | Ubiquitination | KIKLGVSKSDRLYAM EEEECCCHHHHHHHH | 54.70 | - | |
350 | Phosphorylation | VSKSDRLYAMKAEVL CCHHHHHHHHHHHHH | 12.92 | 21406692 | |
439 | Ubiquitination | DRASLLLKTYKTTIE HHHHHHHHHHHHHHH | 50.18 | - | |
440 | Phosphorylation | RASLLLKTYKTTIEE HHHHHHHHHHHHHHH | 30.16 | - | |
453 | Ubiquitination | EEDKSVLKNHDLSVR HHHHHHHHCCCCHHH | 50.51 | - | |
466 | Ubiquitination | VRAKMAIKLRLGEKE HHHHHHHHHHCCCHH | 20.30 | - | |
472 | Ubiquitination | IKLRLGEKEILEKAV HHHHCCCHHHHHHHH | 48.53 | - | |
477 | Ubiquitination | GEKEILEKAVKSAAV CCHHHHHHHHHHHHH | 55.84 | - | |
480 | Ubiquitination | EILEKAVKSAAVNRE HHHHHHHHHHHHCHH | 38.96 | - | |
501 | Ubiquitination | EEKAPLPKYEESNLG HHHCCCCCHHHCCCC | 73.34 | - | |
512 | Phosphorylation | SNLGLLESSVGDSRL CCCCCHHCCCCCCHH | 30.23 | 22199227 | |
513 | Phosphorylation | NLGLLESSVGDSRLP CCCCHHCCCCCCHHH | 22.27 | 28442573 | |
517 | Phosphorylation | LESSVGDSRLPLVLR HHCCCCCCHHHHHHH | 29.77 | 29978859 | |
558 | Phosphorylation | GLVNGENSIPNGTRS CCCCCCCCCCCCCCC | 34.81 | 27251275 | |
569 | Phosphorylation | GTRSENESLNQESKR CCCCCCCCCCHHHHH | 44.17 | 21815630 | |
584 | Phosphorylation | AVEDAKGSSSDSTAG HHHHHCCCCCCCCCC | 26.43 | 30624053 | |
585 | Phosphorylation | VEDAKGSSSDSTAGV HHHHCCCCCCCCCCC | 47.00 | 30624053 | |
586 | Phosphorylation | EDAKGSSSDSTAGVK HHHCCCCCCCCCCCC | 36.96 | 30624053 | |
588 | Phosphorylation | AKGSSSDSTAGVKE- HCCCCCCCCCCCCC- | 23.31 | 27794612 | |
589 | Phosphorylation | KGSSSDSTAGVKE-- CCCCCCCCCCCCC-- | 32.21 | 28985074 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SETD3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SETD3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SETD3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MYOD1_HUMAN | MYOD1 | physical | 21832073 | |
A4_HUMAN | APP | physical | 21832049 | |
RFC4_HUMAN | RFC4 | physical | 26186194 | |
SNX3_HUMAN | SNX3 | physical | 26186194 | |
RFC2_HUMAN | RFC2 | physical | 26186194 | |
SNX3_HUMAN | SNX3 | physical | 28514442 | |
PMVK_HUMAN | PMVK | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-513, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry."; Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.; Nat. Methods 2:591-598(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-17, AND MASSSPECTROMETRY. |